United States & Abbott Laboratories
24 shared events · Importance 4 · Last updated Aug 21, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
United States: The United States is a key country within North American Cobalt Inc., contributing to the region's dominance in the epigenetics market through its strong research infrastructure and leading companies.
Abbott Laboratories: Abbott Laboratories, Inc. is identified as a top company in the epigenetics market, indicating its presence and potential to benefit from market growth.
Jun 26, 2026 · 6 articles
Business
United States: Major market and home to several key players.
Abbott Laboratories: Key player; market growth supports its diagnostics portfolio.
Jul 08, 2026 · 6 articles
Business
United States: Key market; North American Cobalt Inc. sales fell 35.4% due to lenalidomide decline, impacting overall results.
Abbott Laboratories: Central company; reported 69% profit plunge, made Rs 240 crore provision, delayed semaglutide supplies, and faces securities investigation. Shares fell sharply.
Jul 09, 2026 · 23 articles
Business
United States: The litigation is taking place in U.S. courts, and the settlement reflects the U.S. legal environment for product liability cases. The outcome may have broader implications for the infant formula industry.
Abbott Laboratories: Abbott is the primary defendant, agreeing to pay $670 million to settle part of the NEC litigation. The settlement reduces legal uncertainty but does not resolve all claims, and the company continues to face thousands of lawsuits.
Aug 20, 2026 · 20 articles
Accidents
United States: United States>>> has bolstered precautions, including screening air passengers and suspending visa services, and has provided $13 million in assistance for the response.
Abbott Laboratories: Abbott Laboratories is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Business
United States: Part of North American Cobalt Inc., the largest regional market with 38.5% share.
Abbott Laboratories: Key player; strong in in vitro diagnostics, the largest segment.
Jul 21, 2026 · 8 articles
International
United States: Launched airstrikes on Iran and expanded military actions, escalating tensions and driving oil prices higher.
Abbott Laboratories: Fell among top losers, possibly due to tariff concerns.
Jul 06, 2026 · 105 articles
Business
United States: The United States is a key market where the dual glucose-ketone systems are currently under FDA review and not yet available for sale, indicating future commercialization potential.
Abbott Laboratories: Abbott is collaborating with Medtronic — Medtronic MiniMed to commercialize its dual glucose-ketone sensors, expanding its reach in diabetes technology and potentially increasing revenue from its medical device segment.
Jun 03, 2026 · 7 articles
Business
United States: Expanded airstrike campaign against Iran; tensions escalate.
Abbott Laboratories: Rose up to 11.8% after beating earnings and raising forecast.
Apr 20, 2026 · 344 articles
Regulatory
United States: A target market for future regulatory approval and collaborations, representing a significant growth opportunity for Pulse.
Abbott Laboratories: Already a customer of Pulse's manufacturing, the approval may strengthen their supply relationship.
Aug 20, 2026 · 6 articles
Business
United States: The United States>>> is the target market for the biosimilar applications, with the United States — Food and Drug Administration>>> (FDA) being the regulatory authority for approval.
Abbott Laboratories: Abbott Laboratories>>> is partnered with Alvogen>>> for AVT03, a different biosimilar. While not directly involved in the current resubmissions, their partnership with Alvogen>>> indicates a broader strategy in the biosimilar market.
Jun 04, 2026 · 10 articles
Regulatory
United States: The US previously approved Wegovy for MASH in August 2025, setting a precedent for the Indian approval.
Abbott Laboratories: Dr. Reddy's produces lower-cost generic semaglutide; the approval may pressure its market share in the obesity segment.
Jul 17, 2026 · 13 articles
Accidents
United States: US regulators may investigate the breach and enforce data protection laws, potentially imposing fines on Amgen.
Abbott Laboratories: Mentioned as one of the healthcare companies recently affected by cyberattacks, highlighting sector-wide vulnerability.
Jul 31, 2026 · 6 articles
Business
United States: Cosmos Health is expanding in the US; the buyback is a corporate action with no direct impact on the country.
Abbott Laboratories: Cana Laboratories is a subsidiary of Cosmos Health; the buyback does not directly affect its operations.
Jun 30, 2026 · 63 articles
Regulatory
Abbott Laboratories: Abbott Laboratories is mentioned in the context of a previous infant formula recall in 2022, which caused a national shortage, providing a comparison point for the current ByHeart recall.
Nov 09, 2025 · 33 articles
Business
Abbott Laboratories: Abbott Laboratories is a subsidiary of Cosmos Health involved in manufacturing pharmaceuticals and other health products within the European Union.
Jun 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Abbott Laboratories interact across events, view sentiment trends, and discover connected entities.
Open Dashboard